Structural Characterization for N-Terminal Domain of Caveolin-l

  • Kim, Jongmin (Department of Molecular Biology, College of Natural Sciences, Dankook University) ;
  • Shin, Jaeyoung (Department of Molecular Biology, College of Natural Sciences, Dankook University) ;
  • Park, Heonyong (Department of Molecular Biology, College of Natural Sciences, Dankook University)
  • Published : 2003.09.01

Abstract

Caveolin-1 is a principal protein in the plasma membrane microdomains called caveolae. Caveolae play an important role in the transcytosis and pinocytosis. Therefore, caveolin-1 is most likely to work for the membrane dynamic events. In addition, caveolin-1 interacts with various signaling molecules. Although caveolin-1 possesses a variety of physiological functions, its structural properties were little construed. Here we analyzed the structural dynamics of the N-terminal caveolin-1 (residues 1-101), in order to better understand the structural properties in terms of its versatile functionality. We first analyzed its oligomeric form using GST-fused N-terminal domain, revealing that it equilibrates between a dimer and monomers in av concentration-dependent manner. The N-terminal domain of caveolin-1 was previously found to form a heptamer, so that our data suggest the dimeric form as an intermediate structure for the heptamer formation. Then, we obtained the folding profile, which indicated that $\DeltaG_{H2O}\;is\;about\;0.5\;\pm0.03$ kcal/mol. The stability of N-terminal domain is relatively low, indicating that N-terminal domain may not be crystalline. Conclusively, the dynamic and flexible structure of N-terminal domain appears more favorable to maintain the versatile functions of caveolin-1.

Keywords

References

  1. Fernandez I, Ying Y, Albanesi J, and Anderson RGW (2002) Mechanism of caveolin filament assembly. Proc Natl Acad Sci USA 99: 11193-11198 https://doi.org/10.1073/pnas.172196599
  2. Fujimoto T (2000) Cell biology of caveolae and its implication for clinical medicine. Nagoya J Med Sci 63: 9-18
  3. Gonzalez E, Kou R, Lin AJ, Golan DE, and Michel T (2002) Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase. J Biol Chem 277: 39554-39560 https://doi.org/10.1074/jbc.M207299200
  4. Li S, Couet J, and Lisanti MP (1996) Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190
  5. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, and Lisanti MP (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270: 15693-15701 https://doi.org/10.1074/jbc.270.26.15693
  6. Liu P, Rudick M, and Anderson RGW (2002) Multiple funtions of caveolin-1. J Biol Chem 277: 41295-41298 https://doi.org/10.1074/jbc.R200020200
  7. Michel JB, Feron O, Sase K, Prabhakar P, and Michel T (1997) Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 272: 25907-25912 https://doi.org/10.1074/jbc.272.41.25907
  8. Okamoto T, Schlegel A, Scherer PE, and Lisanti MP (1998) Caveolins, a family of scaffolding proteins for organizing preassembled signaling complexes at the plasma membrane. J Biol Chem 273: 5419-5422 https://doi.org/10.1074/jbc.273.10.5419
  9. Park H, Go YM, Darji R, Choi JW, Lisanti MP, Maland MC, and Jo H (2000) Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase. Am J Physiol 278: H1285-H1293
  10. Park H, Go YM, John PLS, Maland MC, Lisanti MP, Abrahamson DR, and Jo H (1998) Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J Biol Chem 273: 32304-32311 https://doi.org/10.1074/jbc.273.48.32304
  11. Parton RG (1994) Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cynochem 42:155-166 https://doi.org/10.1177/42.2.8288861
  12. Parton RG (1996) Caveolae and caveolins. Curr Opin Cell Biol 8: 542-548 https://doi.org/10.1016/S0955-0674(96)80033-0
  13. Razani B and Lisanti MP (2001) Caveolin-deficient mice: insights into caveolar fuction human disease. J Clin Invest 108:1553-1561 https://doi.org/10.1172/JCI200114611
  14. Santoro MM and Bolen DW (1988) Unfolding free energy change determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using differ denaturants. Biochemistry 27: 8063-8068 https://doi.org/10.1021/bi00421a014
  15. Scheiffele P, Verkade P, Fra AM, Virta H, Simons K, and Ikonen E (1998) Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J Cell Biol 140: 795-806 https://doi.org/10.1083/jcb.140.4.795
  16. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, and Lisanti MP (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolin 1 and 2 colocalize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272: 29337-29346 https://doi.org/10.1074/jbc.272.46.29337
  17. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, and Lisanti MP (1995) Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 270: 16395-16401 https://doi.org/10.1074/jbc.270.27.16395